scholarly article | Q13442814 |
P356 | DOI | 10.1161/01.RES.86.9.939 |
P698 | PubMed publication ID | 10807865 |
P2093 | author name string | Q Zheng | |
R T White | |||
G F Schreiner | |||
L W Stanton | |||
A A Protter | |||
A Lam | |||
D Damm | |||
A M Kapoun | |||
B L Garrick | |||
L J Garrard | |||
P2860 | cites work | Basic local alignment search tool | Q25938991 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | myocardial infarction | Q12152 |
P304 | page(s) | 939-945 | |
P577 | publication date | 2000-05-01 | |
P1433 | published in | Circulation Research | Q2599020 |
P1476 | title | Altered patterns of gene expression in response to myocardial infarction | |
P478 | volume | 86 |
Q46295022 | A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction |
Q74800826 | A role of heparin-binding epidermal growth factor-like growth factor in cardiac remodeling after myocardial infarction |
Q53665417 | Altered gene expression profiles of rat lung in response to an emission particulate and its metal constituents. |
Q35009694 | Analysis of altered genomic expression profiles in the senescent and diseased myocardium using cDNA microarrays |
Q44022389 | Analysis of gene expression profile in p130(Cas)-deficient fibroblasts |
Q41811962 | Analysis of region specific gene expression patterns in the heart and systemic responses after experimental myocardial ischemia |
Q34459962 | Application of industrial scale genomics to discovery of therapeutic targets in heart failure |
Q38826375 | Biomarkers in cardiovascular disease: Statistical assessment and section on key novel heart failure biomarkers |
Q36708340 | Cardiac Fibrosis: The Fibroblast Awakens |
Q36229704 | Cardiopoietic programming of embryonic stem cells for tumor-free heart repair |
Q38291461 | Cardioprotective effect of salvianolic acid B on large myocardial infarction mediated by reversing upregulation of leptin, endothelin pathways, and abnormal expression of SERCA2a, phospholamban in rats |
Q35542589 | Cardiovascular genomics |
Q36672272 | Cardiovascular genomics: a current overview of in vivo and in vitro studies |
Q36955513 | Cathepsin A inhibition attenuates myocardial infarction-induced heart failure on the functional and proteomic levels |
Q46578290 | Comparison of cardioprotective effects using salvianolic acid B and benazepril for the treatment of chronic myocardial infarction in rats |
Q94101299 | Current Awareness on Comparative and Functional Genomics |
Q81540101 | Cytokine expression profiling of the myocardium reveals a role for CX3CL1 (fractalkine) in heart failure |
Q38349629 | DNA Microarray Analysis of Hippocampal Gene Expression Measured Twelve Hours after Hypoxia-Ischemia in the Mouse |
Q48483728 | DNA array reveals altered gene expression in response to focal cerebral ischemia |
Q48427055 | DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. |
Q34322737 | DNA microarrays in neuropsychopharmacology |
Q34301391 | Day/night rhythms in gene expression of the normal murine heart |
Q30279093 | Development of target-specific liposomes for delivering small molecule drugs after reperfused myocardial infarction |
Q34088449 | Discrete microstructural cues for the attenuation of fibrosis following myocardial infarction |
Q33947987 | Dose-dependent and independent temporal patterns of gene responses to ionizing radiation in normal and tumor cells and tumor xenografts |
Q36420256 | Dysregulated expression of microRNAs and mRNAs in myocardial infarction |
Q34652525 | Earliest changes in the left ventricular transcriptome postmyocardial infarction |
Q38499082 | Early biventricular molecular responses to an acute myocardial infarction |
Q44314940 | Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study |
Q36442713 | Enhanced engraftment, proliferation, and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes |
Q35978591 | Expression profiling of cardiovascular disease |
Q35788752 | Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy |
Q38423857 | Extracellular matrix communication and turnover in cardiac physiology and pathology |
Q38632188 | Extracellular matrix-mediated cellular communication in the heart. |
Q33231757 | Fibroblast migration after myocardial infarction is regulated by transient SPARC expression |
Q40328847 | Fibulin-6 regulates pro-fibrotic TGF-β responses in neonatal mouse ventricular cardiac fibroblasts |
Q73154345 | Gene expression profiling in biliary atresia |
Q34096360 | Gene expression profiling of cardiovascular disease models |
Q35162514 | Gene expression profiling--a new approach in the study of myocardial ischemia |
Q33930977 | Gene program for cardiac cell survival induced by transient ischemia in conscious pigs |
Q37101612 | Genetic manipulation of periostin expression in the heart does not affect myocyte content, cell cycle activity, or cardiac repair |
Q37187381 | Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling |
Q34049499 | Genome informatics: current status and future prospects |
Q38521995 | Global gene expression in human myocardium-oligonucleotide microarray analysis of regional diversity and transcriptional regulation in heart failure. |
Q37131600 | IGF-1 expression in infarcted myocardium and MGF E peptide actions in rat cardiomyocytes in vitro. |
Q36015690 | Identification and characterization of a novel Schwann and outflow tract endocardial cushion lineage-restricted periostin enhancer. |
Q36748674 | Identification of a core set of genes that signifies pathways underlying cardiac hypertrophy |
Q78514192 | Identification of alterations in gene expression in rat recipients with long-term-surviving cardiac grafts |
Q77924186 | Identification of candidate genes for Sjögren's syndrome using MRL/lpr mouse model of Sjögren's syndrome and cDNA microarray analysis |
Q34571329 | Identification of temporal and region-specific myocardial gene expression patterns in response to infarction in swine. |
Q40419506 | In vivo matrix metalloproteinase-7 substrates identified in the left ventricle post-myocardial infarction using proteomics |
Q36641588 | Integrative genomics in cardiovascular medicine |
Q38477579 | Interaction network analysis revealed biomarkers in myocardial infarction |
Q27303167 | Intrapericardial delivery of gelfoam enables the targeted delivery of Periostin peptide after myocardial infarction by inducing fibrin clot formation |
Q35542423 | Matricellular proteins in cardiac adaptation and disease |
Q36621873 | Mechanisms of Cardiac Regeneration |
Q104268824 | Mep1a contributes to Ang II-induced cardiac remodeling by promoting cardiac hypertrophy, fibrosis and inflammation |
Q53652238 | Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. |
Q54561528 | Microarray analysis reveals the role of matrix metalloproteinases in mouse experimental autoimmune myocarditis induced by cardiac myosin peptides. |
Q35128069 | Microarray analysis: a novel research tool for cardiovascular scientists and physicians. |
Q35109796 | Microarrays: new tools for transplantation research |
Q35936390 | Molecular genetics and genomics of heart failure |
Q38359506 | Molecular profiling of anemia in acute renal allograft rejection using DNA microarrays |
Q37276394 | Myocardial metabolic regulation through peroxisome proliferator-activated receptor alpha after myocardial infarction |
Q35135768 | Novel mechanisms mediating stunned myocardium |
Q54976930 | Olmesartan attenuates pressure-overload- or post-infarction-induced cardiac remodeling in mice. |
Q37716879 | Origin, development, and differentiation of cardiac fibroblasts |
Q73832854 | Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation |
Q33968020 | Periostin advances atherosclerotic and rheumatic cardiac valve degeneration by inducing angiogenesis and MMP production in humans and rodents. |
Q37222921 | Periostin as a heterofunctional regulator of cardiac development and disease |
Q41267688 | Periostin down-regulation attenuates the pro-fibrogenic response of hepatic stellate cells induced by TGF-β1. |
Q53540644 | Periostin induces proliferation of differentiated cardiomyocytes and promotes cardiac repair. |
Q46285375 | Periostin is a negative regulator of mineralization in the dental pulp tissue |
Q36502829 | Periostin is essential for cardiac healing after acute myocardial infarction |
Q47887025 | Periostin is expressed within the developing teeth at the sites of epithelial-mesenchymal interaction |
Q39670748 | Periostin promotes ovarian cancer angiogenesis and metastasis |
Q37678557 | Periostin promotes renal cyst growth and interstitial fibrosis in polycystic kidney disease |
Q36883843 | Periostin-binding DNA aptamer inhibits breast cancer growth and metastasis |
Q28386686 | Periostin-like-factor and Periostin in an animal model of work-related musculoskeletal disorder |
Q34042381 | Perspectives for vascular genomics |
Q35124031 | Polymorphisms of the LTA gene may contribute to the risk of myocardial infarction: a meta-analysis |
Q42011791 | Postmyocardial infarct remodeling and heart failure: potential contributions from pro- and antiaging factors |
Q35544461 | Precursor Tissue Analogs as a Tissue-Engineering Strategy |
Q38522841 | Predicting gene ontology biological process from temporal gene expression patterns. |
Q46844094 | Protective effects of hydroxysafflor yellow A on acute and chronic congestive cardiac failure mediated by reducing ET-1, NOS and oxidative stress in rats |
Q42280481 | Protective effects on myocardial infarction model: delivery of schisandrin B using matrix metalloproteinase-sensitive peptide-modified, PEGylated lipid nanoparticles |
Q37591626 | Protein profiling of plasma proteins in dairy cows with subclinical hypocalcaemia |
Q36100558 | Reciprocal transcriptional regulation of metabolic and signaling pathways correlates with disease severity in heart failure |
Q34368756 | Regulation of gene expression with thyroid hormone in rats with myocardial infarction |
Q28384638 | Role of TNF alpha and PLF in bone remodeling in a rat model of repetitive reaching and grasping |
Q53441756 | Role of healing-specific-matricellular proteins and matrix metalloproteinases in age-related enhanced early remodeling after reperfused STEMI in dogs. |
Q37871839 | Role of matricellular proteins in cardiac tissue remodeling after myocardial infarction |
Q28088349 | Role of periostin and its antagonist PNDA-3 in gastric cancer metastasis |
Q45225467 | S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes |
Q90362748 | STAT3 for Cardiac Regenerative Medicine: Involvement in Stem Cell Biology, Pathophysiology, and Bioengineering |
Q34179052 | Selection of reference genes in different myocardial regions of an in vivo ischemia/reperfusion rat model for normalization of antioxidant gene expression |
Q37115656 | Sildenafil augments early protective transcriptional changes after ischemia in mouse myocardium |
Q52111668 | Spearman correlation identifies statistically significant gene expression clusters in spinal cord development and injury. |
Q35805680 | TSC-22 up-regulates collagen 3a1 gene expression in the rat heart |
Q89241989 | Targeting TGFβ Signaling to Address Fibrosis Using Antisense Oligonucleotides |
Q53306185 | Temporal cardiac remodeling post-myocardial infarction: dynamics and prognostic implications in personalized medicine. |
Q26830787 | The dynamic role of cardiac fibroblasts in development and disease |
Q37421326 | The multifaceted role of periostin in tumorigenesis |
Q37981902 | The multiple facets of periostin in bone metabolism |
Q34092865 | The myocardial contractile response to physiological stress improves with high saturated fat feeding in heart failure |
Q37254881 | Transcriptional profiling of HMGB1-induced myocardial repair identifies a key role for Notch signaling |
Q33969250 | Transcriptome from circulating cells suggests dysregulated pathways associated with long-term recurrent events following first-time myocardial infarction. |
Q33325887 | Uncovering a macrophage transcriptional program by integrating evidence from motif scanning and expression dynamics |
Q47588490 | Uncovering the transcriptional circuitry in skeletal muscle regeneration |
Q37709242 | Using systems biology approaches to understand cardiac inflammation and extracellular matrix remodeling in the setting of myocardial infarction |
Q88636831 | Vitamin K‑dependent proteins involved in bone and cardiovascular health (Review) |
Q80163888 | Washout of heme-containing proteins dramatically improves tetrazolium-based infarct staining |
Q37389353 | Will global transcriptome analysis allow the detection of novel prognostic markers in coronary artery disease and heart failure? |
Q73092755 | [Proteomics and cardiovascular disease] |
Q28216506 | cDNA microarray analysis of changes in gene expression induced by neuronal hypoxia in vitro |
Q28588837 | periostin null mice exhibit dwarfism, incisor enamel defects, and an early-onset periodontal disease-like phenotype |
Search more.